chr10-73674791-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The ENST00000374094.9(AGAP5):āc.1869C>Gā(p.Asp623Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 30)
Exomes š: 0.000012 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
AGAP5
ENST00000374094.9 missense
ENST00000374094.9 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 0.448
Genes affected
AGAP5 (HGNC:23467): (ArfGAP with GTPase domain, ankyrin repeat and PH domain 5) Predicted to enable GTPase activator activity and metal ion binding activity. Predicted to be involved in regulation of catalytic activity. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
SYNPO2L-AS1 (HGNC:55242): (SYNPO2L antisense RNA 1)
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.25445563).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGAP5 | NM_001144000.4 | c.1869C>G | p.Asp623Glu | missense_variant | 8/8 | ENST00000374094.9 | NP_001137472.1 | |
BMS1P4-AGAP5 | NR_160426.1 | n.4136C>G | non_coding_transcript_exon_variant | 20/20 | ||||
BMS1P4-AGAP5 | NR_160425.1 | n.3348C>G | non_coding_transcript_exon_variant | 19/19 | ||||
BMS1P4-AGAP5 | NR_160427.1 | n.3280C>G | non_coding_transcript_exon_variant | 18/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGAP5 | ENST00000374094.9 | c.1869C>G | p.Asp623Glu | missense_variant | 8/8 | 1 | NM_001144000.4 | ENSP00000363207 | A2 | |
SYNPO2L-AS1 | ENST00000668336.1 | n.546G>C | non_coding_transcript_exon_variant | 2/2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 1AN: 151764Hom.: 0 Cov.: 30 FAILED QC
GnomAD3 genomes
AF:
AC:
1
AN:
151764
Hom.:
Cov.:
30
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000438 AC: 1AN: 228148Hom.: 0 AF XY: 0.00000793 AC XY: 1AN XY: 126154
GnomAD3 exomes
AF:
AC:
1
AN:
228148
Hom.:
AF XY:
AC XY:
1
AN XY:
126154
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000123 AC: 18AN: 1459622Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 726130
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
18
AN:
1459622
Hom.:
Cov.:
30
AF XY:
AC XY:
8
AN XY:
726130
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000659 AC: 1AN: 151764Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74132
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
151764
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
74132
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2022 | The c.1869C>G (p.D623E) alteration is located in exon 8 (coding exon 8) of the AGAP5 gene. This alteration results from a C to G substitution at nucleotide position 1869, causing the aspartic acid (D) at amino acid position 623 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;D
REVEL
Benign
Sift
Benign
.;T;T
Sift4G
Benign
T;T;T
Polyphen
1.0
.;.;D
Vest4
MutPred
Gain of disorder (P = 0.0709);.;Gain of disorder (P = 0.0709);
MVP
ClinPred
T
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at